Timothy Williams, SVP and General Counsel at Vanda Pharmaceuticals Inc. ($VNDA), sold shares once on the open market in the last year, totaling $350,755. His most recent sale occurred on March 2, 2026. These VNDA insider sales rank 7,235th among 11,678 individual insiders, below the average sale amount of $8.6 million across 6.37 transactions. Williams made no open market purchases in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | Vanda Pharmaceuticals Inc. | $VNDA | Williams Timothy | SVP & General Counsel | S | Common Stock | 42434 | $8.27 | 377,450.0000 | 59,108,030 | 10.11% | 0.07% |
| Feb. 18, 2026 | Vanda Pharmaceuticals Inc. | $VNDA | Williams Timothy | SVP & General Counsel | A | Common Stock | 125000 | $0.00 | 419,884.0000 | 59,108,030 | 42.39% | 0.21% |
| March 1, 2025 | Vanda Pharmaceuticals Inc. | $VNDA | Williams Timothy | SVP & General Counsel | F | Common Stock | 26941 | $4.76 | 294,884.0000 | 58,316,044 | 8.37% | 0.05% |
| Feb. 18, 2025 | Vanda Pharmaceuticals Inc. | $VNDA | Williams Timothy | SVP & General Counsel | A | Common Stock | 125000 | $0.00 | 321,825.0000 | 58,316,044 | 63.51% | 0.21% |
| March 5, 2024 | Vanda Pharmaceuticals Inc. | $VNDA | Williams Timothy | SVP & General Counsel | S | Common Stock | 8941 | $4.18 | 196,825.0000 | 0 | 4.35% | 0.00% |
| March 4, 2024 | Vanda Pharmaceuticals Inc. | $VNDA | Williams Timothy | SVP & General Counsel | S | Common Stock | 8147 | $4.41 | 205,766.0000 | 0 | 3.81% | 0.00% |
| Feb. 16, 2024 | Vanda Pharmaceuticals Inc. | $VNDA | Williams Timothy | SVP & General Counsel | A | Common Stock | 125000 | $0.00 | 213,913.0000 | 0 | 140.59% | 0.00% |